Economic Evaluation of the Dr. Bart Application in Individuals With Knee and/or Hip Osteoarthritis

التفاصيل البيبلوغرافية
العنوان: Economic Evaluation of the Dr. Bart Application in Individuals With Knee and/or Hip Osteoarthritis
المؤلفون: Frank J. A. van den Hoogen, Cornelia H. M. van den Ende, K. Bevers, Job van der Palen, T. Pelle
المصدر: Arthritis Care & Research, 74, 945-954
Arthritis Care & Research, 74, 6, pp. 945-954
Arthritis Care and Research, 74(6), 945-954. Wiley
سنة النشر: 2022
مصطلحات موضوعية: Male, medicine.medical_specialty, Visual analogue scale, Cost-Benefit Analysis, Osteoarthritis, Hip, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], law.invention, Quality of life (healthcare), Rheumatology, Willingness to pay, Randomized controlled trial, law, Activities of Daily Living, Health care, eHealth, Humans, Medicine, Aged, Patient Activation Measure, business.industry, Middle Aged, Osteoarthritis, Knee, Economic evaluation, Quality of Life, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Physical therapy, Female, Quality-Adjusted Life Years, business
الوصف: Contains fulltext : 251427.pdf (Publisher’s version ) (Open Access) OBJECTIVE: To evaluate the cost-utility and cost-effectiveness of the dr. Bart app compared to usual care in people with osteoarthritis (OA) of the knees and hips, applying a health care payer perspective. METHODS: This economic evaluation was conducted alongside a 6-month randomized controlled trial that included 427 participants. The dr. Bart app is a stand-alone eHealth application that invites users to select pre-formulated goals (i.e., "tiny habits") and triggers for a healthier lifestyle. Self-reported outcome measures were health care costs, quality-adjusted life years (QALYs) according to the EuroQol 5-dimension 3-level (EQ-5D-3L) descriptive system, the EuroQol visual analog scale (QALY VAS), patient activation measure 13 (PAM-13), and 5 subscales of the Knee Injury and Osteoarthritis Outcome Score/Hip Disability and Osteoarthritis Outcome Score. Missing data were multiply imputed, and bootstrapping was used to estimate statistical uncertainty. RESULTS: The mean ± SD age of the study participants was 62.1 ± 7.3 years, and the majority of participants were female (72%). Health care costs were lower in the intervention group compared to the group who received usual care (€-22 [95% confidence interval €-36, -3]). For QALY and QALY VAS, the probability of the dr. Bart app being cost-effective compared to usual care was 0.71 and 0.67, respectively, at a willingness-to-pay (WTP) of €10,000 and 0.64 and 0.56, respectively, at a WTP of €80.000. For self-management behavior, symptoms, pain, and activities of daily living, the probability that the dr. Bart app was cost-effective was >0.82, and the probability that the dr. Bart app was cost-effective in the areas of activities and quality of life was
وصف الملف: application/pdf
تدمد: 2151-464X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f59894229a997f5763bda8e6652d4f9
http://hdl.handle.net/2066/251427
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....1f59894229a997f5763bda8e6652d4f9
قاعدة البيانات: OpenAIRE